JNCE - Jounce Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5183.66M
Enterprise Value 36.39k
Trailing P/E N/A
Forward P/E 1-4.72
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)2.82
Price/Book (mrq)1.76
Enterprise Value/Revenue 30.00
Enterprise Value/EBITDA 6-0.00

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018


Profit Margin -41.99%
Operating Margin (ttm)-48.00%

Management Effectiveness

Return on Assets (ttm)-7.65%
Return on Equity (ttm)-20.19%

Income Statement

Revenue (ttm)65.2M
Revenue Per Share (ttm)2.00
Quarterly Revenue Growth (yoy)54.70%
Gross Profit (ttm)34.31M
EBITDA -27.46M
Net Income Avi to Common (ttm)-27.38M
Diluted EPS (ttm)-0.84
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)189.87M
Total Cash Per Share (mrq)5.76
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.93
Book Value Per Share (mrq)3.16

Cash Flow Statement

Operating Cash Flow (ttm)-63.61M
Levered Free Cash Flow (ttm)12.93M

Trading Information

Stock Price History

Beta (3Y Monthly) 3.91
52-Week Change 3-72.00%
S&P500 52-Week Change 39.76%
52 Week High 322.44
52 Week Low 32.66
50-Day Moving Average 36.15
200-Day Moving Average 34.86

Share Statistics

Avg Vol (3 month) 3226.6k
Avg Vol (10 day) 3175.21k
Shares Outstanding 532.97M
Float 19.32M
% Held by Insiders 113.32%
% Held by Institutions 179.73%
Shares Short (Mar 29, 2019) 4578.09k
Short Ratio (Mar 29, 2019) 41.69
Short % of Float (Mar 29, 2019) 43.70%
Short % of Shares Outstanding (Mar 29, 2019) 41.75%
Shares Short (prior month Feb 28, 2019) 4624.64k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A